LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

June Emerging Medical Technologies Report

Published January 2014 | 28 Pages | 30 Exhibits |

Start Free Trial Request Info
snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Buy This Report Subscribe To All Reports

Overview

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in June 2014. Additionally, read LSI's "Innovator of the Month" Interview with:

- Fred Khosravi

All companies include technology, market(s), key executive, and contact information.

Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

This report may be purchased separately or is automatically provided to subscribers of LSI's Emerging Medical Technologies&reg Database.

 

Table of Contents

BRIEF TECHNOLOGY DESCRIPTIONS FOR COMPANIES COVERED

  • A barrier film medical device platform which separates adjacent organs from adhering to each other after surgery
  • A device for hydrophilic guidewire control, as an alternative to a torque device
  • A diagnostic biomarker that can be applied to a breast cancer patient's tumor sample to predict whether she would benefit from taxane-based chemotherapy
  • A fast, secure closure system for intravenous access catheters that eliminates blood loss, cross contamination and reduces nursing labor
  • A technology for harvesting autogolous, adipose-derived stem cells for use in treating knee, back and joint pain, arthritis or ligament or tendon injuries
  • Affordable portable, power-free, surgical instrument sterilization
  • An orthopedic table extension to assist surgeons in performing minimally invasive direct anterior hip replacement surgery
  • Biocompatible, rice-grain sized, subdermal implant with a proprietary nanoporous membrane to provide long-term, constant-rate delivery of therapeutic macromolecules for up to a year
  • Biomedical devices for delivering anesthesia
  • Carbon nanotube fiber technology to treat ventricular arrhythmia
  • Catheter device that enables chemotherapy delivery in a targeted manner, reducing patient side effects and improving treatment efficacy
  • Collagen replenishment therapies for soft tissue therapeutic applications
  • Cost-effective vein visualization tool that increases the ability of nurses, physicians, and caregivers to locate and easily access veins for IVs, shots and blood samples
  • Disposable electroencephalography (EEG) and cerebral function monitoring (CFM) products for term and preterm infants
  • Effective and cost competitive proprietary scaffold technology for the healing of chronic wounds, that incorporates oxygen and pro-regeneration molecule delivery
  • Electrical-based treatment to remineralize tooth defects/decay
  • Embolic microspheres and delivery system for the peripheral vascular treatment of disorders such as uterine fibroids, hepatocellular carcinoma and benign prostatic hyperplasia
  • Hand-held, integrated, real-time, nanoparticle-based diagnostic device to detect staph and other bacterial infections at the point of care in 30 minutes or less
  • Innovative blood pumps based on membrane wave technology
  • Low cost, simple-to-use, handheld laboratory for 15-minute diagnosis of disease at the patient's side
  • Magnetic intra-ureteral stent that employs a proximity sensing system to allow surgeons to more precisely localize and avoid the ureter during pelvic and colorectal surgeries
  • Microfluidic bioreactor technology to produce the world's first donor-independent human platelets from human induced pluripotent stem cells
  • Neuro diagnostic information device with a particular focus on concussion (mTBI) and Alzheimer's disease
  • Pharmacological materials including mesenchymal stem cells into a bioengineered polymer gel topically applied to non-healing wounds in all clinical care settings
  • Proprietary products for single-cell analysis and characterization using picodroplets
  • The first antibacterial catheter to be self-sterilizing while residing in a patient
  • Tissue-engineered nerve grafts for repairing damage to the peripheral and central nervous systems, involving peripheral nerve injury, spinal cord injury, traumatic brain injury and stroke
  • Transcatheter mitral valve replacement system to treat patients with mitral regurgitation
  • Transdermal drug delivery technology
  • Wearable technology solution that continuously and non-invasively monitors blood glucose levels, and communicates the data to a mobile phone
Work with us

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.

Request Info LSI Europe ‘24 LSI USA ‘25
lsi logo
Contact Customer Login

Events

Market Intelligence

Resources

Schedule an exploratory call

Request Info  

17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647

714-847-3540

© 2024 Life Science Intelligence, Inc., All Rights Reserved.